Viewing data from:

PYRIDOSTIGMINE BROMIDE

ANDA

PYRIDOSTIGMINE BROMIDE | A211181 | MLV PHARMA LLC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MESTINON(TE code: AB)

API Supply Chain6 active DMFs8 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

BAUSCH HEALTH US LLCPYRIDOSTIGMINE BROMIDE

DMF 55051984

PATHEON AUSTRIA GMBH AND CO KGPYRIDOSTIGMINE BROMIDE

DMF 105931993

PROCOS SPAPYRIDOSTIGMINE BROMIDE

DMF 160352002

MAITHRI LABORATORIES PRIVATE LTDPYRIDOSTIGMINE BROMIDE USP

DMF 350242020

SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTDPYRIDOSTIGMINE BROMIDE

DMF 393792024

GLOBAL CALCIUM PRIVATE LTDPYRIDOSTIGMINE BROMIDE USP

DMF 396372024

HOFFMANN LA ROCHE INCInactivePYRIDOSTIGMINE BROMIDE

DMF 69391987

DELMAR CHEMICALS INCInactivePYRIDOSTIGMINE BROMIDE

DMF 88001990

UNICHEM LABORATORIES LTDInactivePYRIDOSTIGMINE BROMIDE

DMF 89521991

CILAG CHEMIE AGInactivePYRIDOSTIGMINE BROMIDE

DMF 90291991

NV ORGANONInactivePYRIDOSTIGMINE BROMIDE

DMF 92161991

HELSINN ADVANCED SYNTHESIS SAInactivePYRIDOSTIGMINE BROMIDE

DMF 108771994

ROCHE PRODUCTS LTDInactivePYRIDOSTIGMINE BROMIDE TABLETS USP 30MG

DMF 119721996

POLYCARBON INDUSTRIES INC DBA PCI SYNTHESISInactivePYRIDOSTIGMINE BROMIDE USP

DMF 156652001

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 60MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 20, 2018

No patent or exclusivity listings for this strength.

#002 — 30MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: May 14, 2019